Aug 31, 2016 09:17 am UTC| Business
Company Announcement Arzerra now approved by U.S. FDA for use in combination with fludarabine and cyclophosphamide in relapsed CLL Approval based on data from Phase III COMPLEMENT 2 study COPENHAGEN, Denmark,...
Global Learning Management System Market 2016-2020 - Market to grow at a CAGR of 23.73%
Aug 31, 2016 09:16 am UTC| Business
Dublin, Aug. 31, 2016 -- Research and Markets has announced the addition of the "Global Learning Management System Market 2016-2020" report to their offering. The global learning...
JD.com Expands Selection of Top Australian Wines with Addition of Wolf Blass Red Label
Aug 31, 2016 08:30 am UTC| Business
BEIJING, Aug. 31, 2016 -- JD.com, Inc. (Nasdaq:JD), China’s largest e-commerce company by revenue, today announced it will be the exclusive authorized online retailer in China for the popular Wolf Blass Red Label brand,...
Aug 31, 2016 08:16 am UTC| Business
Dublin, Aug. 31, 2016 -- Research and Markets has announced the addition of the "Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need...
RealManage Makes the 2016 Inc. 5000 List as One of the Fastest Growing Private Companies in America
Aug 31, 2016 07:11 am UTC| Business
CARROLLTON, Texas, Aug. 31, 2016 -- For the second year in a row, RealManage has been named to the esteemed Inc. 5000 list as one of the fastest growing privately held companies in America with 52% growth over the last...
Aug 31, 2016 07:01 am UTC| Business
SANTA CLARA, Calif., Aug. 31, 2016 -- Infoblox Inc. (NYSE:BLOX), the network control company, today announced results of the Infoblox Security Assessment Report for the second quarter of 2016, which finds that 40...
FRO - Second Quarter and Six Months 2016 Results
Aug 31, 2016 06:06 am UTC| Business
HAMILTON, Bermuda, Aug. 31, 2016 -- Frontline Ltd. (the "Company" or "Frontline"), today reported unaudited results for the three and six months ended June 30, 2016: Highlights Achieved net income attributable to...